Skip to main content

Table 1 CTA protein expression in PTL subtypes

From: Immunohistochemical analysis of the expression of MAGE-A and NY-ESO-1 cancer/testis antigens in diffuse large B-cell testicular lymphoma

Patients

Histological subtype

MAGE-A1(77B mAb)

Multi-MAGE-A(57B mAb)

NY-ESO-1(D8.38 mAb)

  

% of positive tumor cells

Staining score

Staining intensity

% of positive tumor cells

Staining score

Staining intensity

% of positive tumor cells

Staining score

Staining intensity

1

FL

0

0

0

90

3

2

80

3

1

2

SLL

0

0

0

0

0

0

0

0

0

3

B-LBL

0

0

0

100

3

1

0

0

0

4

DLBCL

0

0

0

0

0

0

10

2

1

5

DLBCL

0

0

0

0

0

0

0

0

0

6

DLBCL

0

0

0

0

0

0

0

0

0

7

DLBCL

100

3

2

0

0

0

0

0

0

8

DLBCL

0

0

0

0

0

0

0

0

0

9

DLBCL

0

0

0

0

0

0

0

0

0

10

DLBCL

0

0

0

0

0

0

0

0

0

11

DLBCL

80

3

2

0

0

0

0

0

0

12

DLBCL

0

0

0

0

0

0

100

3

1

13

DLBCL

10

2

1

0

0

0

0

0

0

14

DLBCL

0

0

0

100

3

2

100

3

2

15

DLBCL

0

0

0

100

3

3

100

3

2

16

DLBCL

0

0

0

100

3

2

100

3

2

17

DLBCL

0

0

0

100

3

2

0

0

0

18

DLBCL

0

0

0

100

3

1

0

0

0

19

DLBCL

0

0

0

100

3

2

100

3

3

20

DLBCL

0

0

0

70

3

1

90

3

1

21

DLBCL

0

0

0

100

3

2

100

3

2

22

DLBCL

0

0

0

100

3

3

0

0

0

23

DLBCL

0

0

0

100

3

2

100

3

1

24

DLBCL

0

0

0

90

3

1

0

0

0

25

DLBCL

0

0

0

80

3

2

0

0

0

26

DLBCL

0

0

0

0

0

0

0

0

0

27

DLBCL

0

0

0

100

3

1

0

0

0

  1. DLBCL (Diffuse Large B-cell Lymphoma), FL (Follicular Lymphoma), SLL (Small Lymphocytic Lymphoma), B-LBL (B-Lymphoblastic Lymphoma).
  2. Staining score (percentage of positive tumor cell): 0 (negative), 1 (<10%), 2 (10–50%), 3 (>50%).
  3. Staining intensity: 0 (negative), 1 (weak), 2 (moderate intensity), 3 (strong intensity).